BioSpace News Archive

This study demonstrates that ThyroSeq can be performed using routine cytology smears, while maintaining the robust diagnostic accuracy.

Ambulatory Duchenne patients who are 5 years and older with a nonsense mutation can now access a treatment that targets the underlying cause

Expansions to its cold chain storage capabilities are complete and ready to meet the growing 3PL and complex channel distribution needs of the pharmaceutical industry.

Got spring fever and want to shed those winter pounds?

uLab Systems, the creator of the innovative aligner planning software, announced the achievement of another significant milestone with over 13,000 cases planned in less than one year.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, is pleased to announce that its CE-accredited activity, “Pharmacists Reaching Out®: Optimizing Patient Management in HR+, HER2– Advanced Breast Cancer, the Role of CDK4/6 Inhibition,” has been awarded overall Best In Class Outcomes of 2019 by the Alliance Industry Summit (AIS)

New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis.

For her pioneering research to explain the biology of the placenta, the crucial organ for pregnancy in humans and most other mammals, Myriam Hemberger, PhD, has been awarded the 2019 March of Dimes and Richard B. Johnston, Jr., MD Prize in Developmental Biology

Fresenius Kabi announced today the immediate availability in the United States of Glycopyrrolate Injection, USP in 0.2 mg per 1 mL and 0.4 mg per 2 mL single dose in Simplist® ready-to-administer prefilled syringes.

Level Brands, Inc. (NYSE American: LEVB) today announced that the Company’s wholly owned cbdMD subsidiary will present at the ThinkEquity Conference on Thursday, May 2, 2019 at 11:00 am ET at the Mandarin Oriental Hotel in New York City